Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma

被引：5
|
作者：
Marr, Kristin [1 ]
Ronsley, Rebecca [1 ]
Nadel, Helen [2 ]
Douglas, Kate [1 ]
Gershony, Sharon [3 ]
Strahlendorf, Caron [1 ,4 ]
Davis, Jeffrey H. [1 ]
Deyell, Rebecca J. [1 ,4 ]
机构：
[1] Univ British Columbia, British Columbia Childrens Hosp, Div Pediat Hematol Oncol & Bone Marrow Transplant, Vancouver, BC, Canada
[2] Stanford Univ, Dept Radiol, Div Nucl Med, Stanford, CA 94305 USA
[3] Univ British Columbia, Dept Radiol, Div Nucl Med, Vancouver, BC, Canada
[4] Univ British Columbia, Child & Family Res Inst, Michael Cuccione Childhood Canc Res Program, Vancouver, BC, Canada
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷 / 04期
关键词：
autologous stem cell transplantation; Hodgkin lymphoma; IGEV; pediatric; HIGH-DOSE THERAPY; CHILDREN; TRANSPLANTATION; DISEASE; ADOLESCENTS; CHEMOTHERAPY; RECURRENT;
D O I：
10.1002/pbc.28167
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We describe 12 pediatric patients (8-16 years) with primary refractory (N = 6) or first relapse (N = 6) Hodgkin lymphoma (HL) treated with ifosfamide, gemcitabine, and vinorelbine (IGEV). The overall response rate to IGEV was 100%, with seven (58%) complete responses (CR) and five (42%) partial responses. Successful CD34(+) stem cell mobilization was achieved in all patients. Following subsequent autologous stem cell transplantation, 10 patients (83%) achieved CR. At a median follow-up of 71 months, 11 patients had no evidence of disease. Five-year second event-free survival and overall survival were 83% +/- 11.0% and 90.0% +/- 9.5%, respectively. IGEV is an effective salvage regimen for children with relapsed/refractory HL.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Salvage therapy with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin for relapsed or refractory pediatric Hodgkin lymphoma. Results of a retrospective series of four children
    Marie Jaffray
    Nimrod Buchbinder
    Anne Lutun
    Pascale Schneider
    Jean-Michel Piquenot
    Jean-Pierre Vannier
    Annals of Hematology, 2015, 94 (8) : 1401 - 1406
  • [42] Activity of vinorelbine/gemcitabine in relapsed/refractory Hodgkin's and non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 207 - 208
  • [43] Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma
    Gulati, Nitya
    Boulad, Farid
    Cancio, Maria I.
    Curran, Kevin J.
    Jackson, Carolyn
    Kernan, Nancy
    Kung, Andrew L.
    O'Reilly, Richard
    Prockop, Susan
    Ramaswamy, Kavitha
    Scaradavou, Andromachi
    Spitzer, Barbara
    Shukla, Neerav
    Steinherz, Peter G.
    Forlenza, Christopher
    BLOOD, 2017, 130
  • [44] Chemo-immunotherapy with Brentuximab Vedotin combined with Ifosfamide, Gemcitabine and Vinorelbine Results in Impressive Activity in Relapsed Refractory Hodgkin Lymphoma
    Abuelgasim, Khadega A.
    Alzahrani, Mohsen
    Alsharhan, Yousef
    Khairi, Moataz
    Hommady, Mohammed
    Gmati, Giamal
    Salama, Hind
    Ali, Osama
    Masuadi, Emad M.
    Alaskar, Ahmed
    Alhejazi, Ayman
    Damlaj, Moussab
    BONE MARROW TRANSPLANTATION, 2018, 53 : 605 - 606
  • [45] Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma
    Michallet, Anne-Sophie
    Guillermin, Yann
    Deau, Benedicte
    Lebras, Laure
    Harel, Stephanie
    Amorin, Sandy
    Reynes, Claire
    Salles, Gilles
    Subtil, Fabien
    Brice, Pauline
    HAEMATOLOGICA, 2015, 100 (07) : E269 - E271
  • [46] Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma
    M Ng
    J Waters
    D Cunningham
    I Chau
    A Horwich
    M Hill
    A R Norman
    A Wotherspoon
    D Catovsky
    British Journal of Cancer, 2005, 92 : 1352 - 1357
  • [47] Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma
    Ng, M
    Waters, J
    Cunningham, D
    Chau, I
    Horwich, A
    Hill, M
    Norman, AR
    Wotherspoon, A
    Catovsky, D
    BRITISH JOURNAL OF CANCER, 2005, 92 (08) : 1352 - 1357
  • [48] Does Choice of Salvage Regimen Impact Stem Cell Mobilization in Hodgkin's Lymphoma?
    Khan, Abdul Moiz
    Venkatesh, Neha
    Uberti, Joseph P.
    Ratanatharathorn, Voravit
    Modi, Dipenkumar
    Ayash, Lois
    Alavi, Asif
    Kin, Andrew
    Matin, Aasiya
    Deol, Abhinav
    BLOOD, 2022, 140 : 7565 - 7566
  • [49] Gemcitabine Plus Vinorelbine as an Effective Salvage Chemotherapeutic Regimen in Cisplatin-Refractory Germ Cell Tumor
    Chen, Jia-Hong
    Chang, Ping-Ying
    Yao, Nai-Shun
    SOUTHERN MEDICAL JOURNAL, 2009, 102 (05) : 546 - 548
  • [50] Ifosfamide salvage treatment before autologous stem cell transplantation in patients with refractory and relapsed Hodgkin's lymphoma:: a GELA experience
    Gisselbrecht, C
    Mounier, N
    Fermé, C
    Brice, P
    ANNALS OF ONCOLOGY, 2003, 14 : 39 - 41
12345